Improving blood sugar control through timed high-intensity exercise

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how the timing of high-intensity interval training (HIIT) can enhance metabolic health in individuals with prediabetes. Participants will undergo a 12-week supervised exercise program, with metabolic assessments conducted before and after the intervention using advanced imaging techniques. The goal is to determine if exercising at specific times of the day can optimize blood glucose levels and improve insulin sensitivity. Continuous glucose and blood pressure monitoring will be employed to track changes throughout the study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pre-diabetes:

  * Fasting plasma glucose: 6.1 to 6.9 mmol/L or
  * 2-hour plasma glucose post 75g OGTT: 7.8 to 11.0 mmol/L and
  * HbA1c: 6.0 to 6.4%
  * or Insulin resistant: glucose clearance rate ≤ 360 ml/kg/min as determined using the Oral Glucose Insulin Sensitivity Index at Time 120 min.
* BMI \> 25 kg/m2
* To be willing and able to adhere to the specifications of the protocol;
* To have signed an informed consent document indicating that they understood the purpose of and procedures required for the study and were willing to participate in the study.

Exclusion Criteria:

* overt cardiovascular disease as assessed by medical history, physical exam, and abnormal ECG
* Treatment with any drug known to affect lipid or carbohydrate metabolism, except statins (to be stopped 3 weeks prior to study A), metformin or anti-hypertensive drugs (to be stopped 7 days prior to the studies);
* presence of liver or renal disease other than uncomplicated NASH or mild isolated proteinuria; uncontrolled thyroid disorder;
* Uncontrolled severe hypertension, systolic pressure ≥ 180 mm Hg or diastolic pressure ≥ 110 mm Hg;
* History of ischemic heart disease, tachyarrhythmia, QT interval prolongation, risk factors for torsade de pointes (eg hypokalemia), or taking any medication known to prolong the QT interval;
* History of serious gastrointestinal disorders (malabsorption, peptic ulcer, gastroesophageal reflux requiring surgery, etc.);
* Presence of a pacemaker;
* Having undergone a PET study or CT scan in the past year;
* Any contraindication to stopping statins for 3 months and stopping an anti-hypertensive medication and metformin for 7 days;
* smoking (\>1 cigarette/day) and/or consumption of \>2 alcoholic beverages per day;
* No blood donation two month prior the study;
* prior history or current fasting plasma cholesterol level \> 7 mmol/l or fasting TG \> 6 mmol/l.

Where it's running

• Centre de recherche du CHUS
  Sherbrooke, Quebec, Canada Recruiting

Study contacts

• Principal investigator: Denis P. Blondin, PhD — Université de Sherbrooke
• Study coordinator: Frédérique Frisch
• Email: frederique.frisch@usherbrooke.ca
• Phone: 819-346-1110

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Orforglipron in adults with overweight at risk for obesity-related problems

  This study tests whether orforglipron can help people who are overweight and have early signs of metabolic or cardiovascular risk.

  Recruiting at 88 sites Phase 3 Eli Lilly and Company · Anniston, Alabama and 179 other locations · NCT07794579

• High-Intensity Interval Training vs. Continuous Endurance Training in Prediabetes

  This study tests whether short bursts of intense exercise or steady, longer workouts can improve blood sugar control and fitness in people with prediabetes.

  Recruiting Riphah International University · Lahore, Punjab Province · NCT07713030

• Metabolic Health Trajectories in Overweight Chinese Adults

  This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.

  Recruiting Zhujiang Hospital · Guangzhou, Guangdong · NCT07584330

• Lowering insulin to reduce liver fat production

  This study will try a short course of diazoxide to lower insulin and see if it reduces the liver's creation of new fat in adults with obesity, insulin resistance, and MASLD.

  Recruiting Phase 1 Columbia University · New York, New York · NCT07403604

• Hands-on nutrition demonstrations added to the Diabetes Prevention Program for people with prediabetes

  This project will test whether adding a 7-week series of healthy cooking and nutrition demos to the Diabetes Prevention Program helps adults at risk for prediabetes stay engaged and put healthy eating into daily life.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT06897982

• Effect of Olive Pomace Oil on Blood Sugar Levels

  This study is testing if adding olive pomace oil to meals can help people with type 2 diabetes or those at risk manage their blood sugar levels better.

  Recruiting Instituto de Ciencia y Tecnología de Alimentos y Nutrición · Madrid, Madrid · NCT06723886

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.